Rheumatoid Arthritis Clinical Trials in Chicago

Showing 421-440 of 3,348 trials

5-SENSE Score Validation Study

NCT06138808

The purpose of this study is to assess how well a new scoring system called the 5-SENSE score can predict where seizures start in the brain using Stereoelectroencephalography (SEEG). The 5-SENSE Score is a 5-point score based on routine presurgical work-up, designed to assist in predicting whether SEEG can identify a focal seizure onset zone, thereby sparing patients the risk of undergoing this invasive diagnostic procedure.

Epilepsy Intractable

Duke University400 participantsStarted Jan 2024

Gainesville, Florida, United States • Chicago, Illinois, United States • Durham, North Carolina, United States +16 more locations

Not Yet RecruitingEARLY Phase 12.2 miles

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

NCT07410312

This study will determine if primary graft dysfunction (which causes low blood oxygen levels and fluid or inflammation in the lungs) after lung transplant can be prevented through the use of the study drug (IL-1 receptor antagonist, Anakinra). In this study, lung transplant participants who are randomized to the treatment group will have the study drug injected into the solution that their donor lungs are kept in prior to transplant.

Lung Transplant Recipient

Northwestern University20 participantsStarted Feb 2026

Chicago, Illinois, United States

5-SENSE Score Validation Study

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

Rheumatoid Arthritis Trials in Other Cities

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

A Study of AZD0120 in Autoimmune Diseases

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Belimumab With Rituximab for Primary Membranous Nephropathy

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Maternal-fetal Immune Responses to Fetal Surgery

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Other Conditions in Chicago